Hsa_circRNA_405159 Is A Novel Biomarker to Evaluate the Efficacy of Neoadjuvant chemoradiotherapy in Rectal Cancer

ABSTRACT: Our study was the first to investigate the role of hsa_circ_004119 in RC of NACRT, providing a biomarker about the efficacy of NACRT. Hsa_circRNA_405159 could be the therapeutic target of rectal cancer to improve the efficiency of neoadjuvant chemoradiation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE166973 | GEO | 2021/02/18

REPOSITORIES: GEO